These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 2127852)
21. Differences in the behavioral profile of circling under amphetamine and apomorphine in rats with unilateral lesions of the substantia nigra. Ziegler M; Szechtman H Behav Neurosci; 1988 Apr; 102(2):276-88, 327. PubMed ID: 3130074 [TBL] [Abstract][Full Text] [Related]
22. Injections of 6-hydroxydopamine in the substantia nigra of the rat brain: morphological and biochemical effects. Buonamici M; Cervini MA; Rossi AC; Sebastiani L; Raffaelli A; Bagnoli P Behav Brain Res; 1990 Apr; 38(1):83-95. PubMed ID: 2112003 [TBL] [Abstract][Full Text] [Related]
23. Conditioned rotational behavior in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra. Carey RJ Brain Res; 1986 Feb; 365(2):379-82. PubMed ID: 3081236 [TBL] [Abstract][Full Text] [Related]
24. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist. Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534 [TBL] [Abstract][Full Text] [Related]
25. The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum. Traub M; Wagner HR; Hassan M; Jackson-Lewis V; Fahn S Eur J Pharmacol; 1985 Nov; 118(1-2):147-54. PubMed ID: 3936723 [TBL] [Abstract][Full Text] [Related]
27. Behavioral changes in 6-hydroxydopamine-treated rotation rats after delivery of various neuromodifying agents by means of a stereotactically implanted pellet to the brain. Yoshida M; Torigoe R; Ohtsuru K; Kuramoto S Stereotact Funct Neurosurg; 1990; 54-55():342-6. PubMed ID: 2127860 [TBL] [Abstract][Full Text] [Related]
28. The anatomical substrate of the turning behaviour seen after lesions in the nigrostriatal dopamine system. Garcia-Munoz M; Patino P; Wright AJ; Arbuthnott GW Neuroscience; 1983 Jan; 8(1):87-95. PubMed ID: 6300729 [TBL] [Abstract][Full Text] [Related]
29. Rotational behavior induced by cocaine analogs in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra: dependence upon dopamine uptake inhibition. Heikkila RE; Cabbat FS; Manzino L; Duvoisin RC J Pharmacol Exp Ther; 1979 Oct; 211(1):189-94. PubMed ID: 573788 [No Abstract] [Full Text] [Related]
30. The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts. Blunt S; Jenner P; Marsden CD Neuroscience; 1991; 40(2):453-64. PubMed ID: 1902916 [TBL] [Abstract][Full Text] [Related]
31. Prostaglandin inhibition of apomorphine-induced circling in mice. Schwarz RD; Uretsky NJ; Bianchine JR Pharmacol Biochem Behav; 1982 Dec; 17(6):1233-7. PubMed ID: 6819586 [TBL] [Abstract][Full Text] [Related]
32. The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine. Costall B; Naylor RJ; Pycock C J Pharm Pharmacol; 1975 Dec; 27(12):943-6. PubMed ID: 2668 [No Abstract] [Full Text] [Related]
33. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway. Costall B; Naylor RJ; Pycock C Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921 [TBL] [Abstract][Full Text] [Related]
34. Phencyclidine-induced ipsilateral rotation in rats with unilateral 6-hydroxydopamine-induced lesions of the substantia nigra. Fessler RG; Sturgeon RD; Meltzer HY Life Sci; 1979 Apr; 24(14):1281-8. PubMed ID: 572902 [No Abstract] [Full Text] [Related]
35. Methylprednisolone treatments alter apomorphine-induced circling in the rat model of 6-hydroxydopamine-induced striatal denervation. Thomas J; Jackson-Lewis V; Fahn S; Cadet JL Int J Neurosci; 1989 Jan; 44(1-2):149-54. PubMed ID: 2518572 [TBL] [Abstract][Full Text] [Related]
36. Denervation-like postsynaptic supersensitivity to dopamine agonists induced by microinjection of colchicine into the substantia nigra pars compacta. Kamata K; Kameyama T; Okuyama S; Hashimoto S; Aihara H Brain Res; 1986 Mar; 367(1-2):1-7. PubMed ID: 3008917 [TBL] [Abstract][Full Text] [Related]
38. The pharmacological and anatomical substrates of the amphetamine response in the rat. Creese I; Iversen SD Brain Res; 1975 Jan; 83(3):419-36. PubMed ID: 234270 [TBL] [Abstract][Full Text] [Related]
39. The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat. Cadet JL; Zhu SM Brain Res; 1992 Nov; 595(2):316-26. PubMed ID: 1467973 [TBL] [Abstract][Full Text] [Related]
40. Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat. Fletcher GH; Starr MS Eur J Pharmacol; 1987 Jun; 138(3):407-11. PubMed ID: 2957221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]